Metabonomic Evaluation of ZHENG Differentiation and Treatment by Fuzhenghuayu Tablet in Hepatitis-B-Caused Cirrhosis.
Metabonomic Evaluation of ZHENG Differentiation and Treatment by Fuzhenghuayu Tablet in Hepatitis-B-Caused Cirrhosis.
复制标题
DOI:
10.1155/2012/453503
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Zhang Y
中科院分区:
文献类型:
--
作者:
Sun S;Dai J;Wang W;Cao H;Fang J;Hu YY;Su S;Zhang Y
In Traditional Chinese Medicine (TCM), treatment based on ZHENG (also called TCM syndrome and pattern) differentiation has been applied for about 3 thousand years, while there are some difficulties to communicate with western medicine. In the present work, metabonomic methods were utilized to differentiate ZHENG types and evaluate the therapeutic efficiency of Fuzhenghuayu (FZHY) tablet in hepatitis-B-caused cirrhosis (HBC). Urine samples of 12 healthy volunteers (control group, CG) and 31 HBC patients (HBCG) were analyzed by gas chromatography mass spectrometry (GC/MS) and multivariate statistical analysis. The significantly changed metabolites between CG and HBCG were selected by PLS-DA loading plot analysis. Moreover, 4 ZHENGs were differentiated mutually, suggesting that there was urine metabolic material basis in ZHENG differentiation. The efficiency of FZHY tablet on subjects with spleen deficiency with dampness encumbrance syndrome (SDDES) and liver-kidney yin deficiency syndrome (LKYDS) was better than that of other syndromes. The efficiency of FZHY treatment based on ZHENG differentiation indicated that accurately ZHENG differentiating could guide the appropriate TCM treatment in HBC.
登录
查看更多内容
影响因子:
2.3
作者:
Li, S.;Zhang, Z. Q.;Wang, Y. Y.
通讯作者:
Wang, Y. Y.
影响因子:
4.9
作者:
Liu C;Sun M;Wang L;Wang G;Chen G;Liu C;Liu P
通讯作者:
Liu P
DOI:
10.1016/j.jpba.2011.02.013
发表时间:
2011-06-01
影响因子:
3.4
作者:
Su, Zhi-Heng;Li, Shu-Qi;Zou, Zhong-Mei
通讯作者:
Zou, Zhong-Mei
影响因子:
29.4
作者:
Bugianesi, E;Leone, N;Rizzetto, M
通讯作者:
Rizzetto, M
影响因子:
4.3
作者:
Liu, Ping;Hu, Yi-Yang;Tang, Bao-Zhang
通讯作者:
Tang, Bao-Zhang